ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2018

CONSISTENT SALES GROWTH DURING 2018; REVENUE INCREASED 8% COMPARED WITH THE PREVIOUS YEAR.

Zinzino’s total revenues for the fourth quarter of 2018 amounted to 164.0 (154.7) MSEK, corresponding to sales growth of 6 % compared to the fourth quarter 2017.

Accumulated for 2018, total revenues amounted to 585.6 (540.3) MSEK, corresponding to an increase of 8% compared with the previous year.

Revenues distributed as follows:

Regions,MSEK Q4 2018 Q4 2017 Difference 2018 2017 Difference
Norden 111,0 121,8 -9% 418,9 426,6 -2%
Baltikum 13,0 11,6 13% 44,8 39,6 13%
Centraleuropa 30,5 13,0 134% 90,2 42,3 113%
Sydeuropa 4,0 3,0 33% 10,7 8,1 32%
Nordamerika 5,5 5,4 2% 21,0 23,8 -12%
164,0 154,7 6% 585,6 540,3 8%


Segments,MSEK Q4 2018 Q4 2017 Difference 2018 2017 Difference
Health 119,2 109,3 10% 426,4 379,4 13%
Coffee 11,6 13,1 -7% 42,5 46,8 -8%
Other 17,3 15,9 0% 53,1 49,4 5%
Faun 15,9 16,4 -4% 63,6 64,7 -2%
164,0 154,7 6% 585,6 540,3 8%

Our revenues for the past year met our forecasted numbers and we expect more growth in 2019 in combination with expansion in several exciting markets," according Dag Bergheim Pettersen, CEO Zinzino "

For more information please contact:
Dag Bergheim Pettersen, CEO Zinzino, tel. +47 (0) 932 25 700 www.zinzino.se

Pictures for free publication:
Marcus Tollbom, tel. +46 (0) 70-190 03 12

Certified Adviser:
Erik Penser Bank Aktiebolag: +46 (0)8 463 83 00 Email: certifiedadviser@penser.se 

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 09:00 the 29th of January, 2019.

Tags:

About Us

Zinzino AB (publ.) is a direct sales company which operates through the EU, North America and Australia. Zinzino markets and sells products in two product lines: Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee and tea. Zinzino owns Norwegian BioActive Foods AS and the research and production unit Faun Pharma AS. Zinzino has over 120 employees. The company has its registered office in Gothenburg, and offices in Helsinki, Riga, Oslo, Florida and Brisbane. Zinzino is a public limited company and its shares are listed on Nasdaq First North.

Subscribe

Documents & Links